Select your language

Other official information and services: www.belgium.be  belgium

  •  Key figures
  •  Data
  •  Graphics
  •  Comments
PROVIDERS & PRESCRIBERS    
Main healthcare providers: Pharmacist biologists 64.07%  
Main prescribers: General practitioners 80.83%  
RATE OF USE    
Average number of interventions (per year) 214,821  
Standardised rate of use (per 100,000 insured persons) 7,287.03
≥ 2 occurences per patient 2021   0.25%
Percentage of outpatient care 98.33%
POPULATION    
Median age 64 years
Max/min ratio of the median age (by district) 1.11
Percentage of women 0.00%
Ratio Preferential scheme/General scheme 0.95
TRENDS    
Trend 2012-2022 24.86%
Trend 2012-2019 33.69%
Trend 2019-2022 6.47%
GEOGRAPHICAL VARIATIONS    
Coefficient of variation 2012-2014 64.77
Coefficient of variation 2020-2022 40.98
Max/min ratio of number of interventions (per 100,000 insured persons, by region) 1.65
Max/min ratio of number of interventions (per 100,000 insured persons, by district) 4.99
DIRECT EXPENDITURE    
Average annual expenditure 615,762  
Average annual expenditure per insured person 0.21  
Max/min ratio of expenditure per insured person (by region) 1.65  
Max/min ratio of expenditure per insured person(by district) 4.99  
Average cost of interventions 2.87  


On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

CODES LABEL CREATION DELETION
433333
433344
Dosage de l’antigène prostatique spécifique (P.S.A.) effectué dans le cadre du dépistage, à partir de 40 ans, chez l’homme présentant des antécédents familiaux de cancer de la prostate diagnostiqué avant l’âge de 65 ans #(Maximum 1) (Règle de cumul 338) (Règle diagnostique 97) 01-02-2011
542850
542861
Dosage de l’antigène prostatique spécifique (P.S.A.) par méthode non-isotopique effectué dans le cadre du dépistage individuel, à partir de 40 ans, chez l’homme présentant des antécédents familiaux de cancer de la prostate diagnostiqué avant l’âge de 65 ans #(Maximum 1) (Règle de cumul 338) (Règle diagnostique 97) 01-02-2011

The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Below is a graph showing the evolution of the breakdown by volume of nomenclature codes used for the rates:

Dosagedu Hommesde40Ansetplus Populationarisque  Nomen

Men older than or equal to 40 years

2022

  • NomenclatureNomenclature codes
  • Age Gender CVAge, gender and CV
  • Rates by sexRates by sex
  • Reimbursement rateReimbursement rate
  • TrendsTrends by region
  • Trends breakTrends break
  • Dot PlotDot Plot
  • MapDistribution map
  • Funnel PlotFunnel plot
  • Patient care settingsPatient care settings
  • Provincial OccurrencesOccurrences by Province
  • National OccurrencesNational Occurrences


WE ARE INTERESTED IN YOUR OPINION

Do you have any experience in this area ? We listen to you !

Send us an email

Download the full report
Download the methodology